Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Polyamine sequestration of 2′3′-cGAMP constrains intercellular transmission and STING engagement to subvert antitumor immunity
Yunjin Ma, Chunyuan Zhao, Jiacheng Guo, Yue Fu, Wei Wang, Jiangong Zhang, Kun Zhao, Xiangbo Meng, Zhongshang Yuan, Chengjiang Gao, Mutian Jia, Ying Qin, Hui Song, Wei Zhao
Yunjin Ma, Chunyuan Zhao, Jiacheng Guo, Yue Fu, Wei Wang, Jiangong Zhang, Kun Zhao, Xiangbo Meng, Zhongshang Yuan, Chengjiang Gao, Mutian Jia, Ying Qin, Hui Song, Wei Zhao
View: Text | PDF
Research Article Immunology Metabolism

Polyamine sequestration of 2′3′-cGAMP constrains intercellular transmission and STING engagement to subvert antitumor immunity

  • Text
  • PDF
Abstract

The cyclic dinucleotide 2′3′–cyclic guanosine monophosphate–adenosine monophosphate (2′3′-cGAMP) serves as a central immunotransmitter that propagates stimulator of interferon gene–dependent (STING-dependent) innate immunity across tissues; however, how microenvironmental metabolites regulate its spatiotemporal dynamics remains unknown. Here, we identified polyamines (spermine and spermidine) as critical rheostats controlling 2′3′-cGAMP functionality. Mechanistically, polyamines sequestered 2′3′-cGAMP into polymer-like aggregates, blocking intercellular propagation and suppressing intracellular STING activation by reducing ligand-receptor binding affinity. Deficiency of spermidine and spermine N1-acetyltransferase 1 (SAT1), the rate-limiting enzyme in polyamine catabolism, elevated polyamine levels to entrap extracellular 2′3′-cGAMP and inhibit STING activation. Synergistic administration of endogenous 2′3′-cGAMP with SAT1 stabilizer N1,N11-diethylnorspermine restored 2′3′-cGAMP bioavailability and STING signaling, facilitated type I interferon responses to reprogram immunologically suppressive tumors into immunologically active states and enhanced tumor clearance. Our study established polyamine–cGAMP interactions as a critical spatiotemporal regulatory mechanism for tissue-level immunity, providing a unified model for metabolite-mediated cyclic GMP-AMP synthase–STING (cGAS-STING) regulation across diseases.

Authors

Yunjin Ma, Chunyuan Zhao, Jiacheng Guo, Yue Fu, Wei Wang, Jiangong Zhang, Kun Zhao, Xiangbo Meng, Zhongshang Yuan, Chengjiang Gao, Mutian Jia, Ying Qin, Hui Song, Wei Zhao

×

Figure 8

DENSpm potentiates antitumor immunity dependent on STING signaling.

Options: View larger image (or click on image) Download as PowerPoint
DENSpm potentiates antitumor immunity dependent on STING signaling.
(A) ...
(A) Experimental scheme for Sting–/– or Ifnar–/– mice bearing subcutaneous tumors. (B) At day 13 after MC38 tumor inoculation, Sting1+/+ mice treated with DENSpm/2′3′-cGAMP combination or Sting1–/– mice treated with DENSpm. ELISA analysis in tumor (n = 5/condition). (C and D) Tumor volume curve (C) and tumor weight (D) of Sting1+/+ mice treated with DENSpm/2′3′-cGAMP combination or Sting1–/– mice treated with DENSpm after MC38 tumor inoculation (n = 8/condition). (E and F) Tumor volume curve (E) and tumor weight (F) of Ifnar1+/+ or Ifnar–/– mice treated with DENSpm/2′3′-cGAMP combination after B16F10 tumor inoculation (n = 6/condition). (G) Experimental scheme for C57BL/6 mice bearing MC38 subcutaneous tumors treated with DENSpm, 2′3′-cGAMP and Clophosome. (H and I) Tumor volume curves (H; n = 8 per condition) and tumor weights (I; n = 7 per condition) of C57BL/6 mice after MC38 tumor inoculation treated with the combination of DENSpm/2′3′-cGAMP and either Clophosome or control liposomes. (J) Experimental scheme for C57BL/6 mice bearing B16F10 subcutaneous tumors treated with DENSpm/doxorubicin combination. (K and L) Tumor volume curves (K; n = 8 per condition), tumor weights (L; n = 8 per condition) of C57BL/6 mice after B16F10 tumor inoculation treated with the combination of DENSpm/doxorubicin. Statistical significance was determined using an unpaired 2-sided t test and adjustments were made for multiple comparisons in B, D, F, I, and L or 2-way ANOVA in C, E, H, and K. The data are shown as the mean ± SEM. *P <0.05, **P <0.01. Similar results were obtained from 3 independent experiments. I.T., intratumoral injection.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts